Regulation, Policy Limits, and Genomic Data

Kevin Slavin - designer and entrepreneur working across technology, biology, and culture joins us on this episode to reflect on what it means to design within living, interconnected systems, and how technology moves forward not just through invention, but through the social and cultural conditions that allow ideas to take root in the world.
Known for his article ‘Design as Participation’, he explores how design changes when “the system is the subject, and you’re downstream of it,” shifting the designer’s role away from control and speed toward humility and participation in complex systems.
He also reflects on the limits of regulation and policy, and shares how his company Fairfield Bio is building marketplace and platform models - using rules, access controls, contracts, and incentive design to build trust and enable fair access to non-human genomic data even when trust is low.
This episode is a reminder that design always encodes the future we choose to optimise for and the role each of us plays in shaping it.

In this episode, Kevin Slavin, whose work spans institutions like MIT Media Lab and New York University, reflects on his shift from working on digital systems to engaging directly with biological research environments and living systems.
The conversation ranged across the realities of working with complex socio-technical and biological systems, the tensions between experimentation and responsibility, and the challenges of coordinating action across institutions, nations, and cultures.
The episode explores what it means to build new infrastructures in a world shaped by power asymmetries, historical extraction, and uneven access to knowledge.
Join us as we discuss how designers and entrepreneurs can navigate uncertainty through structured marketplaces.

Key Highlights
👉 Technological progress isn’t driven by invention alone; it advances based on social norms, cultural adoption, and the institutions that shape how new tools actually enter the world.
👉 Regulation and policy struggle to govern complex systems at scale - so governance must be designed into platforms through incentives, access rules, and contracts.
👉 Global coordination fails when trust is low, so systems should be designed to align interests even between actors who don’t share values.
👉 Historical extraction has created deep mistrust around biological data. Benefit-sharing mechanisms must be embedded by design to tackle this.
👉 Platforms aren’t neutral, and therefore builders must take responsibility for what kinds of behaviour their systems reward or exclude.
👉 Designing metrics that prioritise long-term value creation over user volume ensures the focus is on building stable growth, rather than fragile products.
👉 Open access holds the risk of misuse and, therefore, access control, vetting, and membership design become core governance tools, not afterthoughts.
👉 Designing infrastructure is designing the future, making founders and designers explicitly choose the outcomes they want their systems to produce, rather than defaulting to speed and scale.

Topics /chapters
(00:00) Design As Participation - INTRO
(01:32) Introducing Kevin Slavin
(03:12) Introducing Design as Participation
(09:47) Design is interconnected
(15:01) How does Fairfield Bio Grapple with Social Nuances
(26:42) The Risks and Benefits of Open-Access Biotechnology
(38:41) Breadcrumbs

Remember that you can always find transcripts and key highlights of the episode on our website: https://www.boundaryless.io/podcast/kevin-slavin

Episode recorded on Dec 01, 25

Find out more about the show and the research at Boundaryless at https://boundaryless.io/resources/podcast/

Get in touch with Boundaryless:

• Twitter: https://twitter.com/boundaryless_
• Website: https://boundaryless.io/contacts
• LinkedIn: https://www.linkedin.com/company/boundaryless-pdt-3eo

Music

Music from Liosound / Walter Mobilio. Find his portfolio here: https://blss.io/Podcast-Music